semaglutide tablets patent expiry launch date The upcoming of the in India in mid-March 2026 is Looming GLP-1 drug patent expirations

14,15 Whey protein encapsulated GSH improved bioavailability and antioxidant capacity in animal models.* A 2021 animal study published in Molecules by Zhang and colleagues investigated both the bioavailability and safety of whey encapsulated GSH

A small 2026 pilot reported greater blood exposure for one proprietary formulation than for standard glutathione

In healthy individuals, GIP accounts for approximately 60-70% of the total incretin effect on insulin secretion, while GLP-1 contributes 30-40%

Fatigue and energy levels Fatigue is a common complaint across all three medications, particularly during the early titration weeks